Hui-chun I. Su

Reproductive Medicine

3855 Health Sciences Dr
La Jolla, CA 92093

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers.

AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers.

Journal: Cancer discovery

Published: June 24, 2024

Showing 1-1 of 1

Last Updated: 09/26/2026